Fig. 1From: A combined 2-D and 3-D QSAR modeling, molecular docking study, design, and pharmacokinetic profiling of some arylimidamide-azole hybrids as superior L. donovani inhibitorsPlot of predicted pIC50 against experimental pIC50Back to article page